Universal Scientific Industrial (Shanghai) Co., Ltd.

SHSE:601231 Stock Report

Market Cap: CN¥34.2b

Universal Scientific Industrial (Shanghai) Future Growth

Future criteria checks 3/6

Universal Scientific Industrial (Shanghai) is forecast to grow earnings and revenue by 26.5% and 11.1% per annum respectively. EPS is expected to grow by 26.6% per annum. Return on equity is forecast to be 14.3% in 3 years.

Key information

26.5%

Earnings growth rate

26.6%

EPS growth rate

Electronic earnings growth32.6%
Revenue growth rate11.1%
Future return on equity14.3%
Analyst coverage

Good

Last updated30 Oct 2024

Recent future growth updates

Results: Universal Scientific Industrial (Shanghai) Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Jul 28
Results: Universal Scientific Industrial (Shanghai) Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Earnings Miss: Universal Scientific Industrial (Shanghai) Co., Ltd. Missed EPS By 7.3% And Analysts Are Revising Their Forecasts

Apr 04
Earnings Miss: Universal Scientific Industrial (Shanghai) Co., Ltd. Missed EPS By 7.3% And Analysts Are Revising Their Forecasts

Recent updates

Some Investors May Be Worried About Universal Scientific Industrial (Shanghai)'s (SHSE:601231) Returns On Capital

Nov 21
Some Investors May Be Worried About Universal Scientific Industrial (Shanghai)'s (SHSE:601231) Returns On Capital

Here's Why Universal Scientific Industrial (Shanghai) (SHSE:601231) Can Manage Its Debt Responsibly

Oct 23
Here's Why Universal Scientific Industrial (Shanghai) (SHSE:601231) Can Manage Its Debt Responsibly

Is There An Opportunity With Universal Scientific Industrial (Shanghai) Co., Ltd.'s (SHSE:601231) 48% Undervaluation?

Sep 17
Is There An Opportunity With Universal Scientific Industrial (Shanghai) Co., Ltd.'s (SHSE:601231) 48% Undervaluation?

Universal Scientific Industrial (Shanghai) Co., Ltd. (SHSE:601231) Looks Inexpensive But Perhaps Not Attractive Enough

Aug 19
Universal Scientific Industrial (Shanghai) Co., Ltd. (SHSE:601231) Looks Inexpensive But Perhaps Not Attractive Enough

Results: Universal Scientific Industrial (Shanghai) Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Jul 28
Results: Universal Scientific Industrial (Shanghai) Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Does Universal Scientific Industrial (Shanghai) (SHSE:601231) Have A Healthy Balance Sheet?

Jul 16
Does Universal Scientific Industrial (Shanghai) (SHSE:601231) Have A Healthy Balance Sheet?

Universal Scientific Industrial (Shanghai)'s (SHSE:601231) Dividend Is Being Reduced To CN¥0.27

Jun 02
Universal Scientific Industrial (Shanghai)'s (SHSE:601231) Dividend Is Being Reduced To CN¥0.27

Returns On Capital Signal Tricky Times Ahead For Universal Scientific Industrial (Shanghai) (SHSE:601231)

May 21
Returns On Capital Signal Tricky Times Ahead For Universal Scientific Industrial (Shanghai) (SHSE:601231)

Some Investors May Be Willing To Look Past Universal Scientific Industrial (Shanghai)'s (SHSE:601231) Soft Earnings

Apr 08
Some Investors May Be Willing To Look Past Universal Scientific Industrial (Shanghai)'s (SHSE:601231) Soft Earnings

Earnings Miss: Universal Scientific Industrial (Shanghai) Co., Ltd. Missed EPS By 7.3% And Analysts Are Revising Their Forecasts

Apr 04
Earnings Miss: Universal Scientific Industrial (Shanghai) Co., Ltd. Missed EPS By 7.3% And Analysts Are Revising Their Forecasts

Universal Scientific Industrial (Shanghai) Co., Ltd. (SHSE:601231) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Mar 04
Universal Scientific Industrial (Shanghai) Co., Ltd. (SHSE:601231) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Earnings and Revenue Growth Forecasts

SHSE:601231 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202677,7493,1803,1403,2617
12/31/202570,0762,5692,4004,1588
12/31/202459,8321,7271,5005,6423
9/30/202461,7421,8523,2644,682N/A
6/30/202461,3121,9653,0794,541N/A
3/31/202461,2862,0053,8775,424N/A
12/31/202360,7921,9485,2746,823N/A
9/30/202362,0432,2814,8196,410N/A
6/30/202366,4412,7435,6287,149N/A
3/31/202367,5612,8982,7764,287N/A
12/31/202268,5163,0601,7643,435N/A
9/30/202268,3122,9063721,907N/A
6/30/202261,9672,392-2,132-433N/A
3/31/202258,3192,052-1,011809N/A
12/31/202155,3001,858-2,617-1,102N/A
9/30/202154,7351,861-1,425-186N/A
6/30/202152,9521,785-453690N/A
3/31/202151,0181,793-254891N/A
12/31/202047,6961,7393801,437N/A
9/30/202040,7121,4026271,862N/A
6/30/202039,6171,3789742,011N/A
3/31/202037,1421,2301,1131,870N/A
12/31/201937,2041,2621,7522,426N/A
9/30/201937,3751,263-428194N/A
6/30/201935,3501,177-264290N/A
3/31/201934,9991,216-385150N/A
12/31/201833,5501,180-719-219N/A
9/30/201831,6631,229-88344N/A
6/30/201829,6191,150N/A510N/A
3/31/201829,4621,214N/A1,033N/A
12/31/201729,7061,314N/A1,239N/A
9/30/201727,6891,136N/A1,744N/A
6/30/201726,9501,097N/A1,587N/A
3/31/201725,5521,008N/A2,055N/A
12/31/201623,984806N/A1,600N/A
9/30/201624,205775N/A2,175N/A
6/30/201624,794736N/A2,266N/A
3/31/201626,639688N/A983N/A
12/31/201527,260761N/A846N/A
9/30/201524,322711N/A-578N/A
6/30/201521,314646N/A-444N/A
3/31/201517,920701N/A324N/A
12/31/201415,873701N/A963N/A
9/30/201415,274676N/A1,132N/A
6/30/201414,744643N/A948N/A
3/31/201414,236556N/A1,170N/A
12/31/201314,272564N/A1,326N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 601231's forecast earnings growth (26.5% per year) is above the savings rate (2.8%).

Earnings vs Market: 601231's earnings (26.5% per year) are forecast to grow faster than the CN market (25.5% per year).

High Growth Earnings: 601231's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 601231's revenue (11.1% per year) is forecast to grow slower than the CN market (13.7% per year).

High Growth Revenue: 601231's revenue (11.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 601231's Return on Equity is forecast to be low in 3 years time (14.3%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 03:17
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Universal Scientific Industrial (Shanghai) Co., Ltd. is covered by 25 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Szeho NgBNP Paribas Securities (Asia)
Trung TranCGS International
Chen HeChasing Securities